Ophthalmic hGM-CSF preparation

Details Ophthalmic hGM-CSF preparation Ophthalmic hGM-CSF preparation

2006-06-23

2010-12-28

Spector, Lorraine (Department: 1647)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S399000, C530S351000, C424S078040

Reexamination Certificate

active

07858582

ABSTRACT:
The present invention provides an external preparation and the method for produce the same, in which said external preparation comprises recombinant human growth hormone or recombinant human granulocyte macrophage colony-stimulating factor and pharmaceutical acceptable carriers. The present invention also relates to application and usage method in preparing medicaments for treatment of various lesions and ulcers, especially corneal lesions and corneal ulcers.

REFERENCES:
patent: 5006509 (1991-04-01), Waago
patent: 5942487 (1999-08-01), Ogawa et al.
patent: 6335038 (2002-01-01), Cavazza
patent: 7026296 (2006-04-01), Gamache
patent: 7335682 (2008-02-01), Chen et al.
patent: 2006/0106104 (2006-05-01), Vehige et al.
patent: 1519022 (2004-08-01), None
patent: 7316066 (1995-12-01), None
patent: WO-97/39768 (1997-10-01), None
English translation of- CN1519022ATRANS , Nov. 2009.
International Search Report mailed Nov. 2, 2006 for PCT Application No. PCT/CN2006/001430 filed Jun. 23, 2006, 5 pages.

Affiliated with

Also associated with

Rating

Ophthalmic hGM-CSF preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic hGM-CSF preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic hGM-CSF preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4236994